|
US2010305306A1
|
|
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
IL197485D0
|
|
Use of vitamin d compounds for the prevention of adhesions
|
|
WO2009013319A1
|
|
Screening, therapy and diagnosis
|
|
US2009081199A1
|
|
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
CA2676512A1
|
|
Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
|
|
WO2008043857A2
|
|
Novel method of treatment of male sub-fertility
|
|
US2010093675A1
|
|
Novel method
|
|
GB0620284D0
|
|
Novel method
|
|
GB0618700D0
|
|
Novel method
|
|
TW200800156A
|
|
1, 25-dihydroxy, 20-cyclopropyl, 26, 27-deuteroalkyl vitamin D3 compounds and methods of use thereof
|
|
AU2006279331A1
|
|
Synthesis of 1alpha-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
|
|
IL177515D0
|
|
Methods for treating interstitial cystitis and related compounds nd compositions
|
|
WO2007039322A1
|
|
Use of vitamin d3 compounds for the treatment of uveitis
|
|
ZA200602385B
|
|
1,3-Diacylated,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
|
|
EP1879596A1
|
|
20-alkyl, gemini vitamin d3 compounds and methods of use thereof
|
|
US2008280860A1
|
|
Use of Vitamin D Compounds to Treat Endometriosis
|
|
US2009298799A1
|
|
Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds
|
|
IL174484D0
|
|
1,3-diacylated, 26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
|
|
NZ543660A
|
|
Therapeutic peptides and method
|
|
AU2005303773A1
|
|
Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
|
